<head>\n<meta name="viewport" content="width=device-width, initial-scale=1.0">\n<link rel="preconnect" href="https://fonts.googleapis.com">\n<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin="">\n<link href="https://fonts.googleapis.com/css2?family=Merriweather:ital,wght@0,300;0,400;0,700;0,900;1,300;1,400;1,700;1,900&amp;family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&amp;display=swap" rel="stylesheet">\n\n\n<style type="text/css"> \n.container {\n    margin: 0;\n    padding: 0;\n    border: 0;\n    font-size: 100%;\n    font: inherit;\n    vertical-align: baseline;\n    font-family: Arial;\n}\n.common {\n    margin: 0;\n    padding: 0;\n    border: 0;\n    font-family: Arial;\n    font-size: 100%;\n}\nbody {\n    line-height: 1.3;\n    margin: 0;\n    font-family: Arial;\n}\nol, ul {\n    list-style: none;\n}\nblockquote, q {\n    quotes: none;\n}\nblockquote:before, blockquote:after, q:before, q:after {\n    content: '';\n    content: none;\n}\ntable {\n    border-collapse: collapse;\n    border-spacing: 0;\n}\np,h1,h2,h3,h4,h5,h6 {\n\tmargin: 0;\n}\n* {\n    -webkit-box-sizing: border-box;\n    -moz-box-sizing: border-box;\n    box-sizing: border-box;\n} \n\n.main_column {\n    width: 100%;\n    height: auto;\n}\n.banner img {\n\twidth: 100%;\n\theight: auto;\n}\n.intro_text {\n\tpadding: 22px 0 18px 25px;\n\tfont-size: 10px;\n\tline-height: 1.1; \n}\n.intro_text ul {\n\tpadding: 0;\n\tmargin: 0;\n\tpadding-top: 2px;\n\tpadding-left: 11px;\n}\n.intro_text ul li {\n\tpadding-bottom: 2px;\n\tposition: relative;\n\tpadding-left: 10px;\n\tfont-size: 10px;\n}\n.intro_text ul li::before {\n\tcontent: "•";\n    color: #03ae9c!important;\n    position: absolute;\n    left: 0px;\n}\n.token_place {\n\twidth: 100%;\n\theight: auto;\n\tmargin-top: 10px;\n}\n.Title{\n\twidth: 90% !important;\n\tmargin: auto !important;\n}\n.approved {\n\tfont-size: 20px !important;\n\tline-height: 26px;\n\ttext-align: center !important; \n\tmargin-bottom: 10px;\n\tcolor:#00af9a !important;\n\tfont-weight: bold;\n}\n.list {\n\tfont-size: 20px;\n\tline-height: 26px;\n\ttext-align: center;\n\tfont-weight: bold;\n\tcolor:#bb0e82 !important;\n}\n.token_column {\n\twidth: 100%;\n    height: auto;\n    display: flex;\n\tfont-family: Arial, Helvetica, sans-serif;\n    justify-content: space-around;\n    padding: 15px 40px;\n}\n.token_left,.token_right {\n\ttext-align: center;\n}\n.LOCATION_heading,.rspv .heading\n{\n\tfont-size: 17px !important;\n\tline-height: 1.2;\n\tfont-weight: 600;\n}\n.line{\n\theight: 1px !important;\n\twidth: 70%;\n\tbackground-color: #00af9a !important; \n\tmargin: auto;\n}\n.rspv {\n\ttext-align: center;\n\tpadding-top: 2px;\n\tpadding-bottom: 0px;\n\tmargin: 0px;\n}\n.rspv span {\n\tfont-size: 17px;\n\tfont-weight: bold;\n}\n.content_column {\n\twidth: 100%;\n    height: auto;\n    display: flex;\n    justify-content: space-between;\n    padding-top: 60px;\n    line-height: 13px;\n\tpadding-left: 20px !important;\n\tpadding-right: 20px !important;\n}\n.column_one {\n\twidth: 33%;\n\tpadding: 0 5px;\n}\n.footer {\n\tdisplay: flex;\n\twidth: 100%;\n\tjustify-content: space-between;\n\tpadding: 15px 25px !important;\n\ttext-align: center;\n}\n.title1 {\n\tfont-size: 13px;\n\tcolor:#bb0e82 !important;\n\tfont-weight: bold;\n\tline-height:16px; \n\tdisplay: block;\n\tpadding-bottom: 4px !important;\n}\n.title {\n\tfont-size: 12px;\n\tcolor:#bb0e82 !important;\n\tfont-family: Arial;\n\ttext-align: left !important;\n\tline-height: 19px;\n\tfont-weight: bold !important;\n\tmargin: 0 !important;\n\tpadding: 0 !important;\n}\n.column_one ul {\n\tpadding-left: 0;\n\tmargin: 0px !important;\n}\n.column_one ul li {\n\tposition: relative;\n\tpadding-left: 10px;\n\tpadding-bottom: 4px !important;\n}\n.column_one ul li::before {\n    content: "•";\n    color: #000000;\n    position: absolute;\n    left: 0px;\n}\n.list_small {\n\tfont-size: 15px;\n\tline-height: 18px;\n\tcolor:#bb0e82 !important;\n}\n.text1 {\n\tcolor:#bb0e82 !important;\n\tfont-weight: normal!important;\n\tfont-size: 14px;\n}\n.f_text {\n\tfont-size: 7px;\n\tline-height: 13px;\n\ttext-align: left;\n\tpadding-top: 13px;\n}\n.footer {\n\tdisplay: flex;\n\talign-items: center;\n}\n.bg {\n\tposition: absolute;\n\ttop: 200px;\n\ttext-align: center;\n\tmargin: auto;\n\twidth: 100%;\n\tz-index: -1;\n}\n.bg img {\n\tmargin: auto;\n\tdisplay: table;\n}\np { \n\tpadding-bottom: 5px !important;\n\tfont-size: 11px;\n\tline-height: 1.2;\n}\nli {\n\tfont-size: 11px;\n\tline-height: 1.2;\n}\nh4 {\n\tmargin: 0;\n\tpadding-bottom: 5px;\n\tfont-size: 12px;\n}\n.rspv1 {\n\tfont-size: 18px;\n\ttext-align: center;\n\tpadding-bottom: 2px;\n\tline-height: 1.2;\n}\n.Details{\n\tpadding: 0px 25px !important;\n}\n@media only screen and (max-width: 1099px) {\n.container {\n    width: 100%;\n}\n\n}\n@page \n{\n\tmargin: 0;\n}\n</style>\n</head>\n<body> \n\t<div class="container"> \n  <div class="main_column">\n   <div class="banner">\n   \t<img src="https://cdnae1.vod309.com/50fd68b9-106b-4550-b5d0-12b045f8b184/0000000/000003/083/376/0/3/assetFiles/images/style/banner.jpg" width="100%">\n   </div>\n   <div class="bg"><img src="https://cdnae1.vod309.com/50fd68b9-106b-4550-b5d0-12b045f8b184/0000000/000002/785/081/0/31/assetFiles/images/images/bg.png" width="100%"></div>\n \t<div class="intro_text">\n\t\tFASENRA is indicated for the add-on maintenance treatment of patients with severe asthma aged 6 years and older, <br>and with an eosinophilic phenotype.\n \t\t<ul>\n \t\t\t<li style="padding-top: 1px !important;">FASENRA is not indicated for treatment of other eosinophilic conditions</li>\n \t\t\t<li>FASENRA is not indicated for the relief of acute bronchospasm or status asthmaticus</li>\n\t\t\t\n \t\t</ul>\n \t</div>\n \t<div class="token_place">\n \t\t<div class="Details">\n\t\t\t<div class="Title">\n\t\t\t\t<div class="approved">EM_Event_vod__c.Topic_vod__r.Approved_Name_AZ__c</div>\n\t\t\t</div>\n\t\t\t <div class="token_list">\n\t\t\t\t <div class="list">EM_Event_vod__c.Formatted_date_AZ_US__c</div>\n\t\t\t\t <div class="list">EM_Event_vod__c.Invitation_Time_AZ_US__c –  EM_Event_vod__c.Invitation_End_Time_AZ_US__c</div>\n\t\t\t\t <div class="list">EM_Event_vod__c.Invitation_Time_Zone_AZ_US__c</div>\n\t\t\t </div>\n\t\t\t <div class="token_column">\n\t\t\t\t <div class="token_left">\n\t\t\t\t\t <div class="LOCATION_heading" style="padding-bottom: 5px;">LOCATION</div>\n\t\t\t\t\t <div class="list_small">EM_Event_vod__c.Location_Name_AZ__c</div>\n\t\t\t\t\t <div class="list_small">EM_Event_vod__c.Location_Address_vod__c</div>\n\t\t\t\t\t <div class="list_small">EM_Event_vod__c.Location_City_AZ__c, EM_Event_vod__c.Location_State_AZ__c EM_Event_vod__c.Location_Zip_AZ__c</div> \n\t\t\t\t </div>\n\t\t\t\t <div class="token_right">\n\t\t\t\t\t<div class="LOCATION_heading" style="padding-bottom: 5px;">PRESENTED BY</div> \n\t\t\t\t\t <div class="list_small">EM_Event_vod__c.Speaker_First_Name_AZ_US__c EM_Event_vod__c.Speaker_Last_Name_AZ_US__c</div>\n\t\t\t\t\t <div class="list_small">EM_Event_vod__c.Speaker_Title_AZ_US__c<o></o></div>\n\t\t\t\t\t <div class="list_small">EM_Event_vod__c.Speaker_Institution_AZ_US__c<o></o></div>\n\t\t\t\t </div>\n\t\t\t </div>\n\t\t\t <div class="rspv" style="padding-bottom: 5px !important;padding-top: 5px !important;"><span class="heading">RSVP IS REQUIRED BY:</span> <span class="text1" id="rsvp_date" style="font-size: 15px;">Thursday, June 27, 2024</span></div>\n\t\t\t <div class="line"></div>\n\t\t\t <div class="rspv"><span>To find out more information or to register, please contact</span></div>\n\t\t\t <div class="rspv1"><span class="text1" style="font-size: 15px;">EM_Event_vod__c.RSVP_Name_AZ__c</span>  |  <span class="text1" style="font-size: 16px;">EM_Event_vod__c.RSVP_Phone_AZ__c</span></div>\n\t\t\t <div class="line"></div>\n\t\t</div>\n\t\t\n \t\t<div class="content_column">\n \t\t\t<div class="column_one">\n \t\t\t\t<div class="title1">IMPORTANT SAFETY INFORMATION </div>\n\t\t\t\t<div class="title" style="text-align: left !important;">CONTRAINDICATIONS</div>\n \t\t\t\t<p>Known hypersensitivity to benralizumab or excipients.</p>\n \t\t\t\t<div class="title" style="text-align: left !important;">WARNINGS AND PRECAUTIONS</div>\n \t\t\t\t<p><b>Hypersensitivity Reactions</b><br>\nHypersensitivity reactions (eg, anaphylaxis, angioedema, urticaria, rash) have occurred after administration of FASENRA. These reactions generally occur within hours of administration, but in some instances have a delayed onset (ie, days). Discontinue in the event of a hypersensitivity reaction.</p>\n<p><b>Acute Asthma Symptoms or Deteriorating\nDisease</b><br>FASENRA should not be used to treat acute asthma symptoms, acute exacerbations, or acute bronchospasm.</p>\n<p><b>Reduction of Corticosteroid Dosage</b><br>\nDo not discontinue systemic or inhaled corticosteroids abruptly upon initiation of therapy with FASENRA. Reductions in corticosteroid dose, if appropriate, should be gradual and performed under the direct supervision of a physician.\nReduction in corticosteroid dose may be associated with systemic withdrawal symptoms and/or unmask </p>\n \t\t\t</div>\n \t\t\t<div class="column_one">\n \t\t\t\t<p>conditions previously suppressed by systemic  corticosteroid therapy.</p>\n \t\t\t\t<p><b>Parasitic (Helminth) Infection</b><br>\nIt is unknown if FASENRA will influence a patient's response against helminth infections. Treat patients with pre-existing helminth infections before initiating therapy with FASENRA. If patients become infected while receiving FASENRA and do not respond to anti-helminth treatment, discontinue\nFASENRA until infection resolves.</p>\n<div class="title" style="text-align: left !important;">ADVERSE REACTIONS</div>\n<p>The most common adverse reactions (incidence\n≥ 5%) include headache and pharyngitis.</p>\n<p>Injection site reactions (eg, pain, erythema, pruritus, papule) occurred at a rate of 2.2% in patients treated with FASENRA compared with 1.9% in patients treated with placebo.</p>\n<div class="title" style="text-align: left !important;">USE IN SPECIFIC POPULATIONS</div>\n<p>A pregnancy exposure registry monitors pregnancy outcomes in women exposed to FASENRA during pregnancy. To enroll call <span style="display: inline-block;">1-877-311-8972</span>  or visit\nwww.mothertobaby.org/fasenra.</p>\n<p>The data on pregnancy exposure from the clinical trials are insufficient to inform on drug-associated risk. Monoclonal antibodies such as benralizumab </p>\n \t\t\t</div>\n<div class="column_one">\n\t<p>are transported across the placenta during the third trimester of pregnancy; therefore, potential effects on a fetus are likely to be greater during the third trimester of pregnancy.</p>\n\t<div class="title" style="text-align: left !important;">INDICATION</div>\n\t<p style="padding-bottom: 3px !important;">FASENRA is indicated for the add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype.</p>\n\t<ul>\n \t\t\t<li>FASENRA is not indicated for treatment of other eosinophilic conditions</li>\n \t\t\t<li>FASENRA is not indicated for the relief of acute bronchospasm or status asthmaticus</li>\n \t\t</ul>\n \t\t<p style="padding-top: 10px !important;padding-bottom: 10px !important;"><b>Please read accompanying full Prescribing Information, including Patient Information.</b></p>\n \t\t<p style="padding-bottom: 10px !important;"><i>You are encouraged to report negative side effects of AstraZeneca prescription drugs by calling 1-800-236-9933. If you prefer to report these to the FDA, either visit www.FDA.gov/medwatch or call <span style="display: inline-block;">1-800-FDA-1088</span>.</i></p>\n\t\t<p>AstraZeneca is committed to conducting business with the highest standards of integrity and professionalism.\nIf you have any comments that could improve the delivery of our promotional education programs, please contact AstraZeneca at 1-800-236-9933.</p>\n</div>\n \t\t</div> \n \t\t</div>\n \t\t<div class="footer">\n \t\t\t<div class="f_text">FASENRA and FASENRA Pen are registered trademarks of the AstraZeneca group of companies. ©2024 AstraZeneca. All rights reserved. US-88434 4/24</div>\n \t\t\t<div class="logo">\n \t\t\t\t<img src="https://cdnae1.vod309.com/50fd68b9-106b-4550-b5d0-12b045f8b184/0000000/000002/211/316/0/875/assetFiles/images/images/AstraZeneca.png" width="120">\n \t\t\t</div>\n \t\t</div>\n \t</div>\n</div>\n\n\x3Cscript>\n\tvar searchThis = document.getElementById('rsvp_date').innerHTML;\n\t var givenyear = searchThis.substring(0, 4);\n\tvar givenmonth = searchThis.substring(5, 7);\n\tvar givendate = searchThis.substring(8, 10);\n\tlet date = new Date(givenyear,givenmonth-1,givendate);\n\tlet day = date.toLocaleString('en-us', {weekday: 'long'});\n\tlet month = date.toLocaleString('default', { month: 'long' });\n\tdocument.getElementById("rsvp_date").innerHTML= day+", "+month+" "+givendate+", "+givenyear;\n\x3C/script>\n\n\n\t</body>